Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Carolina Martinez Ciarpaglini"'
Autor:
Carolina Martinez-Ciarpaglini, Daniela S Thommen, Nicole C T van Grieken, Joep Grootjans, Sarah Derks, Tessa S Groen-van Schooten, Rosalia Franco Fernandez, Emma N Bos, Jens Seidel, Job Saris, Tania C Fleitas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Tertiary lymphoid structures (TLSs) are thought to stimulate antitumor immunity and positively impact prognosis and response to immune checkpoint blockade. In gastric cancers (GCs), however, TLSs are predominantly found in GC with poor pro
Externí odkaz:
https://doaj.org/article/785d4f4c841145b58d42944ccbc30db0
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
Autor:
Tania Fleitas-Kanonnikoff, Carolina Martinez‐Ciarpaglini, Josefina Ayala, Cinthia Gauna, Rita Denis, Ita Yoffe, Silvia Sforza, María Teresa Martínez, Alicia Pomata, Maider Ibarrola‐Villava, Sipan Arevshatyan, Verónica Burriel, Diego Boscá, Oscar Pastor, Ana Ferrer‐Martinez, Francisca Carrasco, Cristina Mongort, Samuel Navarro, Gloria Ribas, Andres Cervantes
Publikováno v:
Cancer Medicine, Vol 8, Iss 6, Pp 3120-3130 (2019)
Abstract Somatic mutation analysis and evaluation of microsatellite instability (MSI) have become mandatory for selecting personalized therapy strategies for advanced colorectal cancer and are not available as routine methods in Paraguay. The aims of
Externí odkaz:
https://doaj.org/article/c4ab06011a3946a985a944f3fdd2eacb
Autor:
Andrés Cervantes, Josefa Castillo, Susana Roselló, Marisol Huerta, Juan Miguel Cejalvo, Pablo Tolosa, Tania Fleitas, Desamparados Roda, Carolina Martinez Ciarpaglini, Noelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella
Primers obtained from PrimerBank database.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611b7a7ee09ed1ad54389f79e7cd43d8
https://doi.org/10.1158/1078-0432.22471488.v1
https://doi.org/10.1158/1078-0432.22471488.v1
Autor:
Andrés Cervantes, Josefa Castillo, Susana Roselló, Marisol Huerta, Juan Miguel Cejalvo, Pablo Tolosa, Tania Fleitas, Desamparados Roda, Carolina Martinez Ciarpaglini, Noelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella
NRF2 expression analysed by Western Blot after subcellular fractionation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8bdcbda32fd416f51e7aac2fddad8e
https://doi.org/10.1158/1078-0432.22471494
https://doi.org/10.1158/1078-0432.22471494
Autor:
Andrés Cervantes, Josefa Castillo, Susana Roselló, Marisol Huerta, Juan Miguel Cejalvo, Pablo Tolosa, Tania Fleitas, Desamparados Roda, Carolina Martinez Ciarpaglini, Noelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella
Purpose:Despite the clinical advantage of the combination of trastuzumab and platinum-based chemotherapy in HER2-amplified tumors, resistance will eventually develop. The identification of molecular mechanisms related to primary and acquired resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb24318b432c5549dbd90e52dd22da8
https://doi.org/10.1158/1078-0432.c.6527910
https://doi.org/10.1158/1078-0432.c.6527910
Autor:
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I. Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez, Pilar Navarro, Josep Tabernero, Roger R. Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Publikováno v:
Scopus
This work has been supported by grants from Fundación científica AECC -Asociación Española contra el Cáncer- (GCAEC20030CERV) to A.Ce., from Instituto de Salud Carlos III (ISCIII) co-funded by the European Union (CP16/00151, PI17/00211, PI20/000
Autor:
Federica Papaccio, Blanca García-Mico, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro-Cervelló, Carolina Martinez-Ciarpaglini, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Juan Antonio Carbonell-Asins, Tania Fleitas, Susana Roselló, Marisol Huerta, Manuel M. Sánchez del Pino, Luís Sabater, Desamparados Roda, Noelia Tarazona, Andrés Cervantes, Josefa Castillo
Publikováno v:
Journal of Experimental & Clinical Cancer Research. 42
Background Patient-derived organoids (PDOs) from advanced colorectal cancer (CRC) patients could be a key platform to predict drug response and discover new biomarkers. We aimed to integrate PDO drug response with multi-omics characterization beyond
Autor:
Carolina Martinez Ciarpaglini, F. Gimeno-Valiente, Valentina Gambardella, Josefa Castillo, Desamparados Roda, Andrés Cervantes, Susana Roselló, P. Tolosa, Juan Miguel Cejalvo, Marisol Huerta, Noelia Tarazona, T. Fleitas
Publikováno v:
Clinical Cancer Research. 25:1639-1649
Purpose: Despite the clinical advantage of the combination of trastuzumab and platinum-based chemotherapy in HER2-amplified tumors, resistance will eventually develop. The identification of molecular mechanisms related to primary and acquired resista
Autor:
Valentina, Gambardella, Francisco, Gimeno-Valiente, Noelia, Tarazona, Carolina, Martinez-Ciarpaglini, Desamparados, Roda, Tania, Fleitas, Pablo, Tolosa, Juan Miguel, Cejalvo, Marisol, Huerta, Susana, Roselló, Josefa, Castillo, Andrés, Cervantes
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(5)
Despite the clinical advantage of the combination of trastuzumab and platinum-based chemotherapy inWe generated lapatinib- and trastuzumab-resistant clones deriving from two differentWe found RPS6 activation and NRF2 to be related to anti-HER2 drug r
Autor:
Lara Navarro, Beatriz Sánchez, Gema Nieto, José Manuel Rodríguez González, Carlos Monteagudo, Carolina Martinez Ciarpaglini, Jaime Agustí
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 27(6)
AIMS The risk assessment of spitzoid lesions is one of the most difficult challenges in dermatopathology practice. In this regard, the loss of p16 expression and the homozygous deletion of CDKN2A, have been pointed in the literature as reliable indic